50 related articles for article (PubMed ID: 38558745)
1. Laparoscopic distal pancreatectomy with splenic preservation for serous cystadenoma: a case report and literature review.
Aluka KJ; Long C; Rickford MS; Turner PL; McKenna SJ; Fullum TM
Surg Innov; 2006 Jun; 13(2):94-101. PubMed ID: 17012149
[TBL] [Abstract][Full Text] [Related]
2. Synchronous resection of pancreatic serous cystadenocarcinoma and liver metastasis: First reported case and review of literature.
Machado MC; Fonseca GM; de Meirelles LR; Siqueira LT; Katz B; Jukemura J
Pancreatology; 2015; 15(6):708-12. PubMed ID: 26463518
[TBL] [Abstract][Full Text] [Related]
3. Primary Serous Cystadenocarcinoma of the Spleen.
Sciberras P; Baitule A; Wilkins A; Buchanan A
Cureus; 2024 Feb; 16(2):e55165. PubMed ID: 38558745
[TBL] [Abstract][Full Text] [Related]
4. Mucinous cystadenocarcinoma of the pancreas diagnosed in postpartum.
Berindoague R; Targarona E; Savelli A; Pernas J; Lloreta J
Langenbecks Arch Surg; 2007 Jul; 392(4):493-6. PubMed ID: 17530280
[TBL] [Abstract][Full Text] [Related]
5. Hand-assisted laparoscopic resection of serous cystadenoma of the pancreas.
Doi R; Ito D; Fujimoto K; Komoto I; Ohta Y; Torii M; Imamura M
Surg Endosc; 2003 Dec; 17(12):2028-31. PubMed ID: 14598159
[TBL] [Abstract][Full Text] [Related]
6. Spleen-preserving distal pancreatectomy with preservation of the splenic artery and vein for intraductal papillary-mucinous tumor (IPMT): three interesting cases.
Kimura W; Fuse A; Hirai I; Suto K; Suzuki A; Moriya T; Sakurai F
Hepatogastroenterology; 2003; 50(54):2242-5. PubMed ID: 14696508
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic distal pancreatectomy with splenic preservation.
Pryor A; Means JR; Pappas TN
Surg Endosc; 2007 Dec; 21(12):2326-30. PubMed ID: 17593458
[TBL] [Abstract][Full Text] [Related]
8. Mucinous cystadenocarcinoma of the spleen - a very rare case of a primary splenic MCN.
Wlaźlak M; Grząsiak O; Wierzchniewska-Ławska A; Hogendorf P; Durczyński A; Strzelczyk J
Pol Przegl Chir; 2020 Dec; 93(2):1-5. PubMed ID: 34057428
[TBL] [Abstract][Full Text] [Related]
9. Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma.
Shi Z; Zhao Q; Lv B; Qu X; Han X; Wang H; Qiu J; Hua K
Clin Transl Med; 2021 May; 11(5):e399. PubMed ID: 34047476
[TBL] [Abstract][Full Text] [Related]
10. Serous cystadenocarcinoma of the spleen.
Chou CK; Chou SC
Radiol Case Rep; 2017 Jun; 12(2):273-277. PubMed ID: 28491168
[TBL] [Abstract][Full Text] [Related]
11. Recent concepts of ovarian carcinogenesis: type I and type II.
Koshiyama M; Matsumura N; Konishi I
Biomed Res Int; 2014; 2014():934261. PubMed ID: 24868556
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry: A diagnostic aid in differentiating primary epithelial ovarian tumors and tumors metastatic to the ovary.
Kriplani D; Patel MM
South Asian J Cancer; 2013 Oct; 2(4):254-8. PubMed ID: 24455652
[TBL] [Abstract][Full Text] [Related]
13. Serous cystadenocarcinoma of the pancreas: report of a case and management reflections.
Bramis K; Petrou A; Papalambros A; Manzelli A; Mantonakis E; Brennan N; Felekouras E
World J Surg Oncol; 2012 Mar; 10():51. PubMed ID: 22400805
[TBL] [Abstract][Full Text] [Related]
14. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
Bayrak R; Haltas H; Yenidunya S
Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
